DLH Holdings wins NIH order and DLH Holdings stock gains 6.11 percent

Published on 10/05/2026 at 19:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The USD 2.00 million project runs for 18 months as new NIH work. DLH Holdings stock costs EUR 3.82 on October 5, 2026 after EUR 3.60.

DLHC, US23335Q1004, Illustration mit AI erstellt.

DLH Holdings (ISIN US23335Q1004) won a USD 2.00 million NIH data governance task order on October 5, 2026, while DLH Holdings stock was trading at EUR 3.82 at Lang & Schwarz at 7:07 p.m. CEST, plus 6.11 percent versus the prior close of EUR 3.60. GlobeNewswire reported that the award represents new work and runs for 18 months.

NIH project expands data role

DLH will design, develop, and pilot a framework for secure access to controlled biomedical research data. The work covers policy harmonization, governance workflows, security, privacy, data rights, and artificial intelligence requirements, according to GlobeNewswire on October 5, 2026.

The pilot will involve the National Heart, Lung, and Blood Institute and at least one additional NIH institute or center. DLH said the project could provide a roadmap for broader NIH adoption, but the USD 2.00 million value is modest beside the companys existing federal-services base.

Quarterly loss sets a tougher baseline

DLHs fiscal third-quarter 2026 revenue was USD 44.23 million, below the USD 50.00 million consensus cited by MarketBeat. The USD 5.77 million shortfall equals 11.54 percent of that consensus, while reported earnings per share of negative USD 1.16 compared with consensus of negative USD 0.17.

The same fiscal-quarter figures show why contract wins matter to the stock story: new awards improve revenue visibility, but they do not immediately erase the earnings gap. MarketBeat also reported that Zacks Research upgraded DLH from strong sell to hold on October 1, 2026, leaving a consensus of one Buy, one Hold, and one Sell rating.

Nasdaq valuation remains small

A separate Nasdaq snapshot showed DLHC at USD 4.24 at 1:06 p.m. ET on October 5, 2026, with a market capitalization of USD 61.5 million. The same snapshot placed the 52-week range at USD 3.38 to USD 8.10, so the company remains a small-cap federal-services contractor even as the NIH award adds a new technology reference point.

DLH stock gains in after-hours trading

DLH Holdings stock was trading at EUR 3.82 at Lang & Schwarz on October 5, 2026 at 7:07 p.m. CEST, up 6.11 percent versus the Lang & Schwarz prior close of EUR 3.60 on October 2, 2026. The move followed a concrete contract announcement, while the fiscal third-quarter revenue and earnings comparison remains the key counterweight.